Document:

EXTENSION AGREEMENT

EXTENSION AGREEMENT

This EXTENSION AGREEMENT is made and entered into effective as of the 30th day of June, 2015, by and between Oakridge Global Energy Solutions, Inc., a Colorado corporation (“Oakridge”); Oak Ridge Micro-Energy, Inc., a Nevada corporation and wholly-owned subsidiary of Oakridge (“Oak Ridge Nevada”); and Expedia Holdings Limited, a corporation organized under the laws of Hong Kong (“Expedia”).

RECITALS

WHEREAS, on or about February 24, 2014, Oakridge and Expedia entered into a Loan Agreement and a Security Agreement; and 

WHEREAS, on or about February 24, 2014, Oak Ridge Nevada and Expedia, entered into an Intellectual Property Security Agreement; and

WHEREAS, pursuant to the Loan Agreement, the term of the Loan Agreement, as previously extended by the parties, expires on June 30, 2015; and

WHEREAS, Oakridge and Expedia desire to further extend the due date of the loan amount and accrued interest under the Loan Agreement to August 31, 2015, and all parties desire to also extend the Security Agreement and the Intellectual Property Security Agreement;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Oakridge and Expedia hereby agree to extend the due date of the loan referenced in the Loan Agreement to August 31, 2015, along with accrued interest, and that such extension shall have no other effect on the Loan Agreement or the liens granted in the Security Agreement or the Oak Ridge Nevada Intellectual Property Security Agreement, whatsoever.

OAKRIDGE GLOBAL ENERGY SOLUTIONS, INC.

Dated: __ July 6, 2015________.

By__/s/Stephen J. Barber__________________

Stephen J. Barber, Chief Executive Officer

OAK RIDGE MICRO-ENERGY, INC.

Dated: __ July 6, 2015________.

By__/s/Stephen J. Barber__________________

Stephen J. Barber, President

EXPEDIA HOLDINGS LIMITED

Dated: __ July 6, 2015________.

By__/s/Jiahe Hong_______________________

Jiahe Hong, Director

Expedia Holdings LimitedJuly 1, 2015

  
 

 

 July 1, 2015
 

 Tami Tharp
 

 

 Dear Ms. Tharp
 

 It is my pleasure to extend the following offer of employment to you on behalf of Oakridge Global Energy Solutions, Inc. This offer is contingent upon your written acceptance.
 

 Title: Chief Financial Officer
 

 Reporting Relationship: The position will report to Lee Arrowood, President
 

 Job Description: As a key member of the Executive Management Team, the Chief Financial Officer will report to the President and assume a strategic role in the overall management of the company. The CFO will have primary day-to-day responsibility for planning, implementing, managing and controlling all financial-related activities of the company.  This will include direct responsibility of accounting, finance, forecasting, strategic planning,, job costing, legal,, property management, deal analysis and negotiations, investor relationships and partnership compliance and private and institutional financing.  Work with the purchasing Manager to develop processes that creates a balance system for inventory decisions and financial savings that impact the business.  This position shall perform all duties within the objectives, standards, and policies of the company as they fit within the overall structure and goals of Oakridge Global Energy Solutions, and other activities as needed to facilitate company success.
 

 Base Salary: Will be paid every other week in installments of $4615.38 which is equivalent to $120,000.00 on an annual basis, and subject to deductions for taxes and other with holdings as required by law or policies of the company.  Annual performance and salary reviews will be conducted as per company policy and specified in Employee Handbook
 

 Non-Compete Agreement: Our standard non-compete agreement must be signed within the first two weeks. A copy of this will be forwarded to you upon your acceptance of this offer.
 

 Benefits: The current standard company health and dental insurance coverage are supplied per company policy. Eligibility for other benefits, including the 401(k) and tuition reimbursement, will generally take place per company policy and availability. Employee contribution to payment benefit plans is determined annually.  401(k) is currently not offered, but will be available starting in Q3 of 2015.  
 

 Stock Options: No stock options are included with this offer.  Employee shall be eligible to participate in future Stock Options based on company policy and availability.
 

 Vacation and Personal Emergency Time Off: Vacation is accrued at 6.15hours per pay period. Which is equivalent to 4 weeks of PTO on an annual basis.
 

 

 
 
 

 Stock Share Incentives: OGES shares in the amount of 50,000 will be offered to you after 30 days of employment.  An additional 100,000 shares will be awarded to you within the first 30 days of a OGES NASDAQ filing 
 

 Merit Increase: Within 30 days of completion of NASDAQ filing and annually thereafter
 

 Phone/Travel Expenses: Normal and reasonable expenses will be reimbursed on a monthly basis per company policy and upon completion of an appropriate expense request form. (See employee handbook).  Expenses are typically paid within 1 to 2 weeks of submission to accounting.
 

 Start Date: July 6, 2015
 

 Your employment with Oakridge Global Energy Solutions is at-will and either party can terminate the relationship at any time with or without cause and with or without notice.
 

 You acknowledge that this letter represents the entire agreement between you and Oakridge global Energy Solutions and that no verbal or written agreements, promises or representations that are not specifically stated in this offer, are or will be binding upon Oakridge Global Energy Solutions.
 

 If you are in agreement with the offer outline above, please sign below. This offer is in effect until 
 

 July 3, 2015
 

 Signatures:
 

 /s/L. Lee Arrowood_____________
 L. Lee Arrowood President
 Oakridge Global Energy Solutions
 

 July 1, 2015
 

 /s/Tami Tharp________________July 3, 2015_
 Tami Tharp                                                DateExhibit 10.1

 

AMENDMENT TO FIRST AMENDMENT AND ACKNOWLEDGEMENT

 

This AMENDMENT TO FIRST AMENDMENT AND
ACKNOWLEDGEMENT (this “Amendment”), dated as of July 7, 2015, is entered into among APOLLO
Medical Holdings, Inc., a Delaware corporation (“Company”), and NNA
of Nevada, Inc., a Nevada corporation (“Purchaser”).

 

RECITALS

 

A.Reference is made to the First Amendment
and Acknowledgement, dated as of February 6, 2015, as amended by the Amendment To First Amendment and Acknowledgement, dated as
of May 13, 2015 (as so amended, the “First Amendment”), made with respect to the Investment Agreement, dated
as of March 28, 2014, between the Company and the Purchaser and certain other documents related thereto. Capitalized terms not
otherwise defined herein shall have the meanings given to such terms in the First Amendment.

 

B.The Company is required to complete
the Company Sale by June 12, 2015 pursuant to the terms of the First Amendment.

 

C.The Company is required to file the
Initial Registration Statement on or prior to the Filing Deadline pursuant to Section 2(a) of the Registration Rights Agreement,
which was amended by the First Amendment to be the 455th calendar day following the Closing Date if the Company Sale
does not occur.

 

D.The Company has requested (i) an extension
for completing the Company Sale until October 15, 2015, (ii) an extension to file the Initial Registration Statement by the 575th
calendar day following the Closing Date if the Company Sale does not occur, and (iii) an extension of the Effectiveness Target
until the 750th calendar day following the Closing Date, and in each case the Purchaser has agreed to provide such extension.

 

STATEMENT OF AGREEMENT

 

NOW, THEREFORE, in consideration
of the mutual provisions, covenants and agreements herein contained, the Company and the Purchaser hereby agree that:

 

(i) the definition of “Company
Sale” set forth in the First Amendment is hereby amended by replacing “June 12, 2015” with “October 15,
2015”.

 

(ii)the definition
of “Filing Deadline” set forth in Section 1 of the Registration Rights Agreement, as amended by the First Amendment,
is hereby amended by replacing the reference to “455th” with “575th”; provided,
however, if the Company Sale shall occur then the Filing Deadline shall mean:

 

“Filing Deadline” means,
with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), the 125th calendar
day following the date of the Company Sale, provided, that if the Filing Deadline falls on a Saturday, Sunday or other day
that the Commission is closed for business, the Filing Deadline shall be extended to the next business day on which the Commission
is open for business.

 

    	 

    	 

    

 

(iii)the definition of “Effectiveness
Target” set forth in Section 1 of the Registration Rights Agreement, as amended by the First amendment, is hereby amended
by replacing the reference to “630th” with “750th”.

 

The Company hereby confirms and agrees that,
after giving effect to this Amendment, the Registration Rights Agreement, the Investment Agreement, the Warrants, the Convertible
Note and the other Transaction Documents, in each case as amended by the First Amendment, remain in full force and effect and enforceable
against the Company in accordance with its respective terms and shall not be discharged, diminished, limited or otherwise affected
in any respect, other than as amended by this Amendment, and the amendment contained herein shall not, in any manner, be construed
to constitute payment of, or impair, limit, cancel or extinguish, any rights of the Purchaser in any of the Transaction Documents,
which shall not in any manner be impaired, limited, terminated, waived or released, but shall continue in full force and effect.
The Company represents and warrants to Purchaser that it has no knowledge of any claims, counterclaims, offsets, or defenses to
or with respect to its obligations under the Investment Agreement or the other Transaction Documents, or if the Company has any
such claims, counterclaims, offsets, or defenses to the Investment Agreement or any other Transaction Document the same are hereby
waived, relinquished, and released in consideration of the execution of this Amendment.

 

This Amendment may
be executed in any number of counterparts and by different parties hereto on separate counterparts, each of which when so executed
and delivered shall be an original, but all of which shall together constitute one and the same instrument.

 

 

    	2

    	 

    

 

IN WITNESS WHEREOF, the parties hereto
have caused this Amendment to be duly executed and delivered by their respective duly authorized officers as of the date first
above written.

 

	 	Company:	 
	 	 	 
	 	APOLLO medical holdings, inc.	 
	 	 	 
	 	By:	/s/ Warren Hosseinion	 
	 	Name:	Warren Hosseinion	 
	 	Title:	CEO	 
	 	 	 	 
	 	 	 	 
	 	Purchaser:	 
	 	 	 
	 	NNA OF NEVADA, INC.	 
	 	 	 
	 	By:	/s/ Mark Fawcett	 
	 	Name:	Mark Fawcett	 
	 	Title:	SVP and Treasurer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00247-of-00352.parquet"}]]